GADOVIST 1MMOLML PREFILLED SYRINGE 5.0 ML Singapore - English - HSA (Health Sciences Authority)

gadovist 1mmolml prefilled syringe 5.0 ml

bayer (south east asia) pte ltd - gadobutrol - injection - 604.720 mg/ml(equiv. 1.0 mmol) - gadobutrol 604.720 mg/ml(equiv. 1.0 mmol)

Gadovist 1mmol/ml solution for injection 7.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gadovist 1mmol/ml solution for injection 7.5ml pre-filled syringes

bayer plc - gadobutrol - solution for injection - 1mmol/1ml

Gadovist 1mmol/ml solution for injection 10ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gadovist 1mmol/ml solution for injection 10ml pre-filled syringes

bayer plc - gadobutrol - solution for injection - 1mmol/1ml

Gadovist 1mmol/ml solution for injection 5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gadovist 1mmol/ml solution for injection 5ml pre-filled syringes

bayer plc - gadobutrol - solution for injection - 1mmol/1ml

Gadovist 1mmol/ml solution for injection 15ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gadovist 1mmol/ml solution for injection 15ml vials

bayer plc - gadobutrol - solution for injection - 1mmol/1ml

Gadovist 1mmol/ml solution for injection 30ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gadovist 1mmol/ml solution for injection 30ml vials

bayer plc - gadobutrol - solution for injection - 1mmol/1ml

GADOVIST 1.0 SOLUTION Canada - English - Health Canada

gadovist 1.0 solution

bayer inc - gadobutrol - solution - 604.72mg - gadobutrol 604.72mg - other diagnostic agents

Gadovist New Zealand - English - Medsafe (Medicines Safety Authority)

gadovist

bayer new zealand limited - gadobutrol 302.36 mg/ml equivalent to 0.5 mmol/ml - solution for injection - 0.5 mmol/ml - active: gadobutrol 302.36 mg/ml equivalent to 0.5 mmol/ml excipient: calcobutrol hydrochloric acid trometamol water for injection

Gadovist 1.0 New Zealand - English - Medsafe (Medicines Safety Authority)

gadovist 1.0

bayer new zealand limited - gadobutrol 604.72mg equivalent to 1 mmol/ml - solution for injection - 1 mmol/ml - active: gadobutrol 604.72mg equivalent to 1 mmol/ml excipient: calcobutrol hydrochloric acid trometamol water for injection - gadovist 1.0 is indicated in adults and children of all ages including full-term newborns for: · contrast enhancement in cranial and spinal magnetic resonance imaging (mri). for spinal mri this includes: differentiation of intra- and extramedullary tumours, demonstration of solid tumour areas in known syrinx, determination of intramedullary tumour spread. gadovist 1.0 is especially suited for high dose indications, such as cases where the exclusion or demonstration of additional foci may influence the therapy or patient management, for detection of very small lesions and for visualisation of lesions that do not readily take up contrast media. gadovist 1.0 is also indicated for perfusion studies such as the diagnosis of stroke, the detection of focal cerebral ischaemia and tumour perfusion. · contrast enhancement in whole body mri including head and neck region, thoracic space, breast, abdomen (pancreas, liver and spleen), pelvis (prostate, bladder and uterus), retroperitoneal space (kidney), extremities and musculoskeletal system. · contrast enhancement in magnetic resonance angiography (ce mra). · contrast enhancement in cardiac mri including assessment of rest and pharmacological stress perfusion and delayed enhancement.

Gadovist 1 mmol/ml inj. sol. i.v. cartr. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

gadovist 1 mmol/ml inj. sol. i.v. cartr. vial

bayer sa-nv - gadobutrol 4,5354 g - solution for injection - 1,0 mmol/ml - gadobutrol 604.72 mg/ml - gadobutrol